Point72 Hong Kong Ltd - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 188 filers reported holding REPLIGEN CORP in Q4 2016. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
Point72 Hong Kong Ltd ownership history of REPLIGEN CORP
ValueSharesWeighting
Q4 2020$586,000
-28.6%
3,059
-53.9%
0.03%
-71.4%
Q2 2020$821,000
+854.7%
6,639
+617.0%
0.09%
+355.0%
Q4 2019$86,000
-21.1%
926
-35.0%
0.02%
-35.5%
Q3 2019$109,000
+2625.0%
1,424
+2273.3%
0.03%
+1450.0%
Q1 2019$4,000
+300.0%
60
+130.8%
0.00%
Q4 2018$1,000
-99.3%
26
-99.3%
0.00%
-100.0%
Q3 2017$141,000
+4600.0%
3,690
+4345.8%
0.10%
+3233.3%
Q4 2016$3,000830.00%
Other shareholders
REPLIGEN CORP shareholders Q4 2016
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders